Yes, diabetes can cause blindness. It is one of the leading causes of vision loss among working-age adults, and in the United States alone, an estimated 9.6 million people are living with diabetic retinopathy, the eye disease responsible for most diabetes-related blindness. Of those, 1.84 million have a vision-threatening form. The good news: blindness from diabetes is largely preventable with early detection and treatment.
How Diabetes Damages the Eyes
Chronically high blood sugar weakens the tiny blood vessels that supply the retina, the light-sensitive tissue lining the back of your eye. Over time, these damaged vessels develop small bulges called microaneurysms, which can leak blood and fluid into the surrounding retinal tissue. The leaked fluid causes swelling, and the blood shows up as small hemorrhages visible during an eye exam, often long before you notice any change in your vision.
As more vessels become blocked, parts of the retina lose their blood supply and become starved of oxygen. Your body responds by growing new blood vessels to compensate, but these replacement vessels are fragile and poorly formed. They rupture easily, spilling blood into the gel-like interior of the eye. They also trigger the growth of scar tissue, which can pull on the retina and detach it. This cascade of leaking, abnormal vessel growth, and scarring is what ultimately leads to severe vision loss and blindness.
Stages of Diabetic Retinopathy
Diabetic retinopathy progresses through two broad stages, and understanding them helps explain why the disease can sneak up on you.
Non-proliferative diabetic retinopathy (NPDR) is the earlier stage. The retina develops microaneurysms, small hemorrhages, and protein deposits called hard exudates. At this point, your visual acuity is generally preserved, and many people have no symptoms at all. But the disease is active beneath the surface. Eyes classified as moderate NPDR have roughly a 9% risk of progressing to the advanced stage, while eyes with severe NPDR carry a 45% risk.
Proliferative diabetic retinopathy (PDR) is the advanced stage. New, abnormal blood vessels push through the inner surface of the retina and extend into the vitreous cavity. Because these vessels are so fragile, they can rupture without warning. A small bleed may produce a handful of dark floaters in your vision. A large one can fill the vitreous with blood and block your sight entirely. Scar tissue from repeated bleeding can also pull the retina away from the back of the eye, a tractional detachment that may cause sudden, permanent vision loss if not treated.
Diabetic Macular Edema
Diabetic macular edema (DME) is a separate but related threat to your vision. It occurs when leaky retinal blood vessels allow fluid to build up in the macula, the small central area of the retina responsible for sharp, detailed vision. DME can develop at any stage of retinopathy, not just the advanced one, and it is the most common reason people with diabetes lose the ability to read, drive, or recognize faces.
When fluid accumulates away from the very center of the macula, you may not notice anything wrong. But once it reaches the center, vision tends to decline gradually over weeks to months. People with DME often describe blurry or washed-out vision, loss of color perception, poor night vision, and difficulty adjusting between bright and dim lighting. Some notice that their vision fluctuates from day to day or even within a single day. Straight lines may appear wavy or distorted.
Other Eye Conditions Linked to Diabetes
Retinopathy gets the most attention, but diabetes raises the risk of other eye diseases too. Older adults with diabetes are about 50% more likely to develop cataracts and roughly 55% more likely to develop glaucoma compared to people without diabetes. Cataracts cloud the eye’s lens and cause gradually blurry vision. Glaucoma damages the optic nerve, typically through elevated pressure inside the eye, and can steal peripheral vision without obvious early symptoms. Both conditions are treatable, but they add to the overall burden diabetes places on your eyesight.
How Quickly Vision Loss Can Develop
The timeline varies significantly depending on the type of diabetes and how well blood sugar is controlled. Nearly all people with type 1 diabetes and more than 60% of those with type 2 develop some degree of retinopathy within the first 20 years of their diagnosis. In one clinical study, the median time from a diabetes diagnosis to detectable retinopathy was about 41 months, or roughly three and a half years, though some individuals showed retinal changes within just a few months.
Early retinopathy does not mean imminent blindness. The progression from mild background changes to vision-threatening disease takes years in most cases, and only a subset of eyes advance to the proliferative stage. That window of time is exactly why regular screening matters so much: it gives doctors the opportunity to intervene before irreversible damage occurs.
Warning Signs to Watch For
In its early stages, diabetic retinopathy typically causes no symptoms at all. That’s what makes it dangerous. By the time you notice visual changes, the disease has often progressed significantly. Symptoms of advancing retinopathy include:
- Floaters: dark spots, strings, or cobweb-like shapes drifting across your vision, caused by blood leaking into the vitreous
- Blurred vision: often from macular edema rather than the retinopathy itself
- Dark or empty patches: areas of your visual field that seem blocked or missing
- Fluctuating vision: clarity that changes noticeably from one day to the next
- Sudden vision loss: a sign of a large vitreous hemorrhage or retinal detachment, requiring urgent care
A sudden shower of floaters or a dark curtain falling over part of your vision is an emergency. These symptoms can signal a major bleed or a detaching retina, and prompt treatment within hours or days can make the difference between saving and losing your sight.
How Diabetic Eye Disease Is Treated
The two primary treatments for vision-threatening diabetic retinopathy are anti-VEGF injections and laser therapy, and they target different parts of the problem.
Anti-VEGF injections work by blocking the growth signal that drives abnormal blood vessel formation. The medication is injected directly into the eye, typically once a month during active treatment, then less frequently as the disease stabilizes. These injections reduce swelling from macular edema, lower the risk of vitreous hemorrhage, and can slow or halt the progression of retinopathy. For many people with DME, anti-VEGF therapy is now the first-line treatment.
Panretinal photocoagulation (PRP) uses a laser to treat the oxygen-starved areas of the retina, which reduces the stimulus for new, abnormal vessel growth. It has been the standard treatment for proliferative retinopathy for decades and remains highly effective at preventing severe vision loss. The laser does intentionally sacrifice some peripheral and night vision in exchange for protecting central sight.
In clinical comparisons, anti-VEGF injections and laser therapy produce similar long-term visual outcomes for proliferative retinopathy. Anti-VEGF offers a small short-term advantage in visual sharpness after one year, but that difference narrows and may disappear within three to five years. The choice between them often depends on the specific pattern of disease, how reliably a person can attend frequent injection appointments, and the treating doctor’s judgment.
For advanced cases involving a large vitreous hemorrhage or retinal detachment, surgery to remove the blood-filled vitreous gel and repair the retina may be necessary.
Screening Recommendations
Because early retinopathy is silent, routine eye exams are the only reliable way to catch it in time. The American Diabetes Association recommends that people with type 2 diabetes get a dilated eye exam at the time of diagnosis, since the disease may have been present for years before it was detected. People with type 1 diabetes should have their first comprehensive eye exam within five years of diagnosis.
After that initial exam, the schedule depends on what’s found. If there’s no sign of retinopathy and blood sugar is well controlled, exams every one to two years are generally sufficient. If any level of retinopathy is present, annual exams become the minimum. Progressing or sight-threatening disease calls for more frequent monitoring. The exam itself involves dilating your pupils so a specialist can view the full retina, either directly or through retinal imaging that captures detailed photographs of the blood vessels.
Reducing Your Risk
The single most important factor in preventing diabetic eye disease is blood sugar control. High glucose is the engine that drives retinal damage, and tighter management consistently reduces the risk of developing retinopathy and slows its progression in people who already have it. Blood pressure control matters too, since hypertension accelerates vessel damage throughout the body, including in the retina. Maintaining healthy cholesterol levels and not smoking further protect the small blood vessels that feed your eyes.
None of this guarantees you’ll avoid retinopathy entirely. Duration of diabetes is a risk factor no one can change, and genetics play a role. But the combination of good metabolic control and regular screening dramatically lowers the odds that diabetes will cost you your sight.